Co-Transplantation of lslets with Mesenchymal Stem Cells and lmmature Dendritic Cells in the Treatment of Mouse Diabetes

Ting-ting WANG,Hong-can WANG,Yu-rong LU,Dong-shuo YE,Deng-ke YANG,Guang-tao ZHANG,Fang-ting ZHANG,Guang-hui LONG,Jian Zhang,Yin-ke YANG

DOI: https://doi.org/10.7612/j.issn.1000-2537.2017.01.007

2017-01-01

Abstract:To establish an effective plan for immune tolerance of islets transplantation, immature dendritic cells ( imDCs) were identified by flow cytometry ( FCM) . Mesenchymal stem cells ( MSCs) were incubated to dif-ferentiate into osteoblasts and islets were identified with dithizone ( DTZ) staining method. From the results of three co-transplantation groups, it was found that transplantation did not significantly prolong graft survival (7 ± 2. 65 d) , but remarkedly decreased blood glucose and glycosylated hemoglobin concentration in the diabetes of mouse by co-transplantation of 200 islets and 2 × 105 imDCs. Co-transplantation of 200 islets with 2 × 105 MSCs could signifi-cantly decrease blood glucose level and prolong graft survival for 8 ± 2. 31 days. Transplantation of 200 islets with 2 × 105 MSCs and 2 × 105 imDCs could not only restore normal blood glucose level, but also significantly prolong graft survival for 12. 6 ± 3. 48 days. This result indicates that co-transplantation of islets with imDCs or MSCs can promote graft survival and reverse blood glucose level, and at the meanwhile effectively control the glycosylated he-moglobin concentration as well, which is better than islets transplantation alone.